Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
41.71
+1.39 (3.45%)
At close: Nov 6, 2025, 4:00 PM EST
41.71
0.00 (0.00%)
After-hours: Nov 6, 2025, 4:40 PM EST
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $5.46 billion as of November 6, 2025. Its market cap has decreased by -61.77% in one year.
Market Cap
5.46B
Enterprise Value
3.83B
1-Year Change
-61.77%
Ranking
Category
Stock Price
$41.71
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $5.46B, an increase of 295.67%. That is a compound annual growth rate of 29.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 5.28B | -48.27% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.38B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |